IL6 and Sepsis: Current studies have shown that many inflammation-based biomarkers, such as IL-6, IL-10, and HMGB1, can reflect the severity of sepsis and correlate well with clinical outcomes, but have proven to be lack generalizability to individual patients—in large part because these biomarkers have common characteristics of early inflammatory response but lack specificity7.